Credit Suisse analyst Andrew M. Kuske upgraded Mercer International Inc. (NASDAQ:MERC) to Outperform from Neutral and raised the price target to $19 (an…
Athira Pharma Inc (NASDAQ: ATHA) shares are falling Wednesday after the company announced topline results from its exploratory ACT-AD Phase 2 study of fosgonimeton in patients with mild-to-moderate Alzheimer's disease.